Amanote Research
Register
Sign In
978. Production of SARS Coronavirus-Like Particles That Bind Host Cells and Serve as Vaccine Antigen
Molecular Therapy
- United States
doi 10.1016/j.ymthe.2005.07.521
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2005
Authors
Unknown
Publisher
Elsevier BV
Related search
Efficient Assembly and Release of SARS Coronavirus-Like Particles by a Heterologous Expression System
FEBS Letters
Genetics
Cell Biology
Molecular Biology
Biochemistry
Structural Biology
Biophysics
Virus-Like Particles of SARS-Like Coronavirus Formed by Membrane Proteins From Different Origins Demonstrate Stimulating Activity in Human Dendritic Cells
PLoS ONE
Multidisciplinary
Isatin Compounds as Noncovalent SARS Coronavirus 3c-Like Protease Inhibitors
How the SARS Coronavirus Causes Disease: Host or Organism?
Journal of Pathology
Forensic Medicine
Pathology
SARS Coronavirus
The Papain-Like Protease Determines a Virulence Trait That Varies Among Members of the SARS-coronavirus Species
PLoS Pathogens
Immunology
Molecular Biology
Virology
Microbiology
Parasitology
Genetics
Virus Like Particles as a Platform for Cancer Vaccine Development
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
Potential Host Range of Multiple SARS-like Coronaviruses and an Improved ACE2-Fc Variant That Is Potent Against Both SARS-CoV-2 and SARS-CoV-1
Vaccine Potential of Nipah Virus-Like Particles
PLoS ONE
Multidisciplinary
